$HDSN
HUDSON TECHNOLOGIES INC /NY Stock $hdsn

$hdsn Overview Financials Valuation SEC Filings Company Website

2017 Q2 Form 10-Q Financial Statement

#000114420417041734 Filed on August 09, 2017

Income Statement

Concept	2017 Q2	2016 Q2
Revenue	$52.23M	$34.61M
YoY Change	50.93%	20.84%
Cost Of Revenue	$34.81M	$24.11M
YoY Change	44.36%	12.55%
Gross Profit	$17.42M	$10.49M
YoY Change	66.05%	45.47%
Gross Profit Margin	33.35%	30.32%
Selling, General & Admin	$3.399M	$2.347M
YoY Change	44.82%	-4.24%
% of Gross Profit	19.51%	22.37%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$600.0K	$530.0K
YoY Change	13.21%	-1.85%
% of Gross Profit	3.44%	5.05%
Operating Expenses	$3.520M	$2.347M
YoY Change	49.98%	-4.24%
Operating Profit	$13.90M	$8.144M
YoY Change	70.68%	71.06%
Interest Expense	$61.00K	$352.0K
YoY Change	-82.67%	49.15%
% of Operating Profit	0.44%	4.32%
Other Income/Expense, Net	-$61.00K	-$352.0K
YoY Change	-82.67%	49.15%
Pretax Income	$13.84M	$7.792M
YoY Change	77.61%	72.2%
Income Tax	$5.314M	$2.962M
% Of Pretax Income	38.4%	38.01%
Net Earnings	$8.525M	$4.830M
YoY Change	76.5%	71.82%
Net Earnings / Revenue	16.32%	13.96%
Basic Earnings Per Share	$0.21	$0.15
Diluted Earnings Per Share	$0.20	$0.14
COMMON SHARES
Basic Shares Outstanding	41.57M	33.13M shares
Diluted Shares Outstanding	43.55M	34.27M shares

Balance Sheet

Concept	2017 Q2	2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$33.70M	$1.500M
YoY Change	2146.67%	0.0%
Cash & Equivalents	$33.67M	$1.500M
Short-Term Investments
Other Short-Term Assets	$6.300M	$2.800M
YoY Change	125.0%	-46.15%
Inventory	$64.60M	$57.80M
Prepaid Expenses
Receivables	$24.50M	$21.90M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$129.1M	$84.00M
YoY Change	53.69%	26.68%
LONG-TERM ASSETS
Property, Plant & Equipment	$7.200M	$7.100M
YoY Change	1.41%	-9.07%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.100M	$2.000M
YoY Change	5.0%	1900.0%
Total Long-Term Assets	$13.30M	$13.60M
YoY Change	-2.21%	-21.14%
TOTAL ASSETS
Total Short-Term Assets	$129.1M	$84.00M
Total Long-Term Assets	$13.30M	$13.60M
Total Assets	$142.4M	$97.60M
YoY Change	45.9%	16.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$9.700M	$4.900M
YoY Change	97.96%	-72.47%
Accrued Expenses	$3.600M	$3.100M
YoY Change	16.13%	675.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$25.60M
YoY Change	-100.0%
Long-Term Debt Due	$100.0K	$300.0K
YoY Change	-66.67%	-97.09%
Total Short-Term Liabilities	$15.60M	$35.60M
YoY Change	-56.18%	24.99%
LONG-TERM LIABILITIES
Long-Term Debt	$100.0K	$4.100M
YoY Change	-97.56%	-7.68%
Other Long-Term Liabilities		$0.00
YoY Change		-100.0%
Total Long-Term Liabilities	$100.0K	$4.100M
YoY Change	-97.56%	-31.37%
TOTAL LIABILITIES
Total Short-Term Liabilities	$15.60M	$35.60M
Total Long-Term Liabilities	$100.0K	$4.100M
Total Liabilities	$15.70M	$39.70M
YoY Change	-60.45%	15.22%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock		$332.0K
YoY Change		1.84%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$126.6M	$57.80M
YoY Change
Total Liabilities & Shareholders Equity	$142.4M	$97.60M
YoY Change	45.9%	16.81%

Cashflow Statement

Concept	2017 Q2	2016 Q2
OPERATING ACTIVITIES
Net Income	$8.525M	$4.830M
YoY Change	76.5%	71.82%
Depreciation, Depletion And Amortization	$600.0K	$530.0K
YoY Change	13.21%	-1.85%
Cash From Operating Activities	-$6.230M	$1.570M
YoY Change	-496.82%	406.45%
INVESTING ACTIVITIES
Capital Expenditures	-$270.0K	-$390.0K
YoY Change	-30.77%	-20.41%
Acquisitions
YoY Change
Other Investing Activities		$0.00
YoY Change
Cash From Investing Activities	-$270.0K	-$390.0K
YoY Change	-30.77%	-20.41%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	20.00K	-820.0K
YoY Change	-102.44%	-168.33%
NET CHANGE
Cash From Operating Activities	-6.230M	1.570M
Cash From Investing Activities	-270.0K	-390.0K
Cash From Financing Activities	20.00K	-820.0K
Net Change In Cash	-6.480M	360.0K
YoY Change	-1900.0%	-64.71%
FREE CASH FLOW
Cash From Operating Activities	-$6.230M	$1.570M
Capital Expenditures	-$270.0K	-$390.0K
Free Cash Flow	-$5.960M	$1.960M
YoY Change	-404.08%	145.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Net Income Loss NetIncomeLoss	14259000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1209000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	60000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	0	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	33000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	19785000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-3988000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5529000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	4143000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	707000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	637000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-637000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	355000	USD
	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	0	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	155000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-328000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-258000	USD
	us-gaap	Interest Paid InterestPaid	142000	USD
	hdsn	Payment Of Deferred Acquisition Cost PaymentOfDeferredAcquisitionCost	528000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1143000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	76000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	34000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	72000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	17593000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-4123000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	907000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1879000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-4148000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	517000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-517000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	593000	USD
	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	5369000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	178000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	4951000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	286000	USD
	us-gaap	Interest Paid InterestPaid	551000	USD
	hdsn	Payment Of Deferred Acquisition Cost PaymentOfDeferredAcquisitionCost	833000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	1833000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	1665000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	21983000	USD
CY2017Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	22599000	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	14451000	USD
CY2017Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	15396000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	4686000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	4686000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1630000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1387000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3056000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3299000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	200000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	200000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	34000	USD
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	6000000	shares
CY2017Q2	us-gaap	Deferred Compensation Arrangement With Individual Common Stock Reserved For Future Issuance DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance	3251340	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	3055037	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	2.7
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	916787	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	306000	USD
CY2012Q2	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	50000000	USD
CY2017Q2	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	50000000	USD
CY2017Q2	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	130000	USD
CY2013Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	40000000	USD
CY2015	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1000000	USD
CY2015	hdsn	Business Combination Provisional Information Initial Accounting Incomplete Adjustment Goodwill BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill	1900000	USD
CY2015	us-gaap	Business Combination Provisional Information Initial Accounting Incomplete Adjustment Intangibles BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles	800000	USD
CY2015	us-gaap	Business Combination Provisional Information Initial Accounting Incomplete Adjustment Inventory BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory	100000	USD
CY2015Q4	us-gaap	Business Combination Contingent Consideration Arrangements Range Of Outcomes Value High BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh	3000000	USD
CY2017Q2	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	2036000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	2532000	USD
CY2017Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2017Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	41625181	shares
CY2017Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41625181	shares
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	6559000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1757000	USD
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	41465820	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41465820	shares
CY2017Q2	us-gaap	Revenues Revenues	52231000	USD
CY2016Q2	us-gaap	Revenues Revenues	34605000	USD
	us-gaap	Revenues Revenues	91061000	USD
	us-gaap	Revenues Revenues	62772000	USD
CY2017Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	34811000	USD
CY2016Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	24114000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	61174000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	44759000	USD
CY2017Q2	us-gaap	Gross Profit GrossProfit	17420000	USD
CY2016Q2	us-gaap	Gross Profit GrossProfit	10491000	USD
	us-gaap	Gross Profit GrossProfit	29887000	USD
	us-gaap	Gross Profit GrossProfit	18013000	USD
CY2017Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1110000	USD
CY2016Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1019000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2149000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2136000	USD
CY2017Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2410000	USD
CY2016Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1328000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4445000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2714000	USD
CY2017Q2	us-gaap	Operating Expenses OperatingExpenses	3520000	USD
CY2016Q2	us-gaap	Operating Expenses OperatingExpenses	2347000	USD
	us-gaap	Operating Expenses OperatingExpenses	6594000	USD
	us-gaap	Operating Expenses OperatingExpenses	4850000	USD
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	13900000	USD
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	8144000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	23293000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	13163000	USD
CY2017Q2	us-gaap	Interest Expense InterestExpense	61000	USD
CY2016Q2	us-gaap	Interest Expense InterestExpense	352000	USD
	us-gaap	Interest Expense InterestExpense	146000	USD
	us-gaap	Interest Expense InterestExpense	623000	USD
CY2017Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	13839000	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	7792000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	23147000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	12540000	USD
CY2017Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5314000	USD
CY2016Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2962000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8888000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4766000	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	8525000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	4830000	USD
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.21
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.15
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.34
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.24
CY2017Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.20
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.33
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.23
CY2017Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41567848	shares
CY2016Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33128518	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41537894	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33008588	shares
CY2017Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43550226	shares
CY2016Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34270337	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43490914	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34045125	shares
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-SIZE: 10pt">Credit Risk</font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of temporary cash investments and trade accounts receivable. The Company maintains its temporary cash investments in highly-rated financial institutions and, at times, the balances exceed FDIC insurance coverage. The Company's trade accounts receivable are primarily due from companies throughout the United States. The Company reviews each customer's credit history before extending credit.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company establishes an allowance for doubtful accounts based on factors associated with the credit risk of specific accounts, historical trends, and other information. The carrying value of the Company’s accounts receivable is reduced by the established allowance for doubtful accounts. The allowance for doubtful accounts includes any accounts receivable balances that are determined to be uncollectible, along with a general reserve for the remaining accounts receivable balances. The Company adjusts its reserves based on factors that affect the collectability of the accounts receivable balances.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">For the six month period ended June 30, 2017, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">two customers each accounted for 10% or more of the Company’s revenues</font> and, in the aggregate these two customers accounted for <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 41</font>% of the Company’s revenues. At June 30, 2017, there were $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">6.5</font> million in outstanding receivables from these customers.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">For the six month period ended June 30, 2016, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">one customer accounted for 25% of the Company’s revenues</font>. At June 30, 2016, there were $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2.1</font> million in outstanding receivables from this customer.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The loss of a principal customer or a decline in the economic prospects of and/or a reduction in purchases of the Company's products or services by any such customer could have a material adverse effect on the Company's operating results and financial position.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-SIZE: 10pt">Estimates and Risks</font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect reported amounts of certain assets and liabilities, the disclosure of contingent assets and liabilities, and the results of operations during the reporting period. Actual results could differ from these estimates.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company utilizes both internal and external sources to evaluate potential current and future liabilities for various commitments and contingencies. In the event that the assumptions or conditions change in the future, the estimates could differ from the original estimates.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Several of the Company's accounting policies involve significant judgments, uncertainties and estimates. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results may differ from these estimates under different assumptions or conditions. To the extent that actual results differ from management's judgments and estimates, there could be a material adverse effect on the Company. On a continuous basis, the Company evaluates its estimates, including, but not limited to, those estimates related to its allowance for doubtful accounts, inventory reserves, and valuation allowance for the deferred tax assets relating to its NOLs and commitments and contingencies. With respect to accounts receivable, the Company estimates the necessary allowance for doubtful accounts based on both historical and anticipated trends of payment history and the ability of the customer to fulfill its obligations. For inventory, the Company evaluates both current and anticipated sales prices of its products to determine if a write down of inventory to net realizable value is necessary. In determining the Company’s valuation allowance for its deferred tax assets, the Company assesses its ability to generate taxable income in the future.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company participates in an industry that is highly regulated, and changes in the regulations affecting our business could affect our operating results. Currently the Company purchases virgin hydrochlorofluorocarbon (“HCFC”) and hydrofluorocarbon (“HFC”) refrigerants and reclaimable, primarily HCFC, HFC and chlorofluorocarbon (“CFC”), refrigerants from suppliers and its customers. Effective January 1, 1996, the Clean Air Act (the “Act”) prohibited the production of virgin CFC refrigerants and limited the production of virgin HCFC refrigerants. Effective January 2004, the Act further limited the production of virgin HCFC refrigerants and federal regulations were enacted which established production and consumption allowances for HCFC refrigerants which imposed limitations on the importation of certain virgin HCFC refrigerants. Under the Act, production of certain virgin HCFC refrigerants is scheduled to be phased out during the period 2010 through 2020, and production of all virgin HCFC refrigerants is scheduled to be phased out by 2030. In October 2014, the EPA published a final rule providing further reductions in the production and consumption allowances for virgin HCFC refrigerants for the years 2015 through 2019 (the “Final Rule”). In the Final Rule, the EPA has established a linear draw down for the production or importation of virgin HCFC-22 that started at approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">22 million pounds in 2015 and reduces by approximately 4.5 million pounds each year and ends at zero in 2020</font>. In October 2016, more than 200 countries, including the United States, agreed to amend the Montreal Protocol to phase down production of HFCs by <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 85</font>% between now and 2047. The amendment establishes timetables for all developed and developing countries to freeze and then reduce production levels and use of HFCs, with the first reductions by developed countries starting in 2019.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">To the extent that the Company is unable to source sufficient quantities of refrigerants or is unable to obtain refrigerants on commercially reasonable terms or experiences a decline in demand and/or price for refrigerants sold by the Company, the Company could realize reductions in revenue from refrigerant sales, which could have a material adverse effect on its operating results and its financial position.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company is subject to various legal proceedings. The Company assesses the merit and potential liability associated with each of these proceedings. In addition, the Company estimates potential liability, if any, related to these matters. To the extent that these estimates are not accurate, or circumstances change in the future, the Company could realize liabilities, which could have a material adverse effect on its operating results and its financial position.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
	us-gaap	Depreciation Depreciation	900000	USD
	us-gaap	Depreciation Depreciation	900000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P2Y2M12D
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	17600000	USD
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	17100000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	34000	USD
	us-gaap	Line Of Credit Facility Interest Rate Description LineOfCreditFacilityInterestRateDescription	Interest charges with respect to loans are computed on the actual principal amount of loans outstanding during the month at a rate per annum equal to (A) with respect to Domestic Rate Loans (as defined in the PNC Facility), the sum of the Alternate Base Rate (as defined in the PNC Facility) plus one half of one percent (.50%) and (B) with respect to Eurodollar Rate Loans, the sum of the Eurodollar Rate plus two and one quarter of one percent (2.25%).
CY2015Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment	1600000	USD
CY2015Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles	1600000	USD
CY2015Q1	us-gaap	Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount	2300000	USD
	us-gaap	Concentration Risk Customer ConcentrationRiskCustomer	two customers each accounted for 10% or more of the Companys revenues
	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	1991-01-11
CY2017Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	2000000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	2500000	USD
	us-gaap	Operating Loss Carryforwards Limitations On Use OperatingLossCarryforwardsLimitationsOnUse	All the Companys remaining NOLs of approximately $4.1 million are subject to annual limitations of $1.3 million
CY2016Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	106000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	187000	shares
CY2017Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
	hdsn	Production And Importation Permission Description ProductionAndImportationPermissionDescription	22 million pounds in 2015 and reduces by approximately 4.5 million pounds each year and ends at zero in 2020
CY2016Q4	hdsn	Production Phase Down Percentage ProductionPhaseDownPercentage	0.85	pure
	us-gaap	Concentration Risk Customer ConcentrationRiskCustomer	one customer accounted for 25% of the Companys revenues

Files In Submission

Name	View Source	Status
0001144204-17-041734-index-headers.html	Edgar Link	pending
0001144204-17-041734-index.html	Edgar Link	pending
0001144204-17-041734.txt	Edgar Link	pending
0001144204-17-041734-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
hdsn-20170630.xml	Edgar Link	completed
hdsn-20170630.xsd	Edgar Link	pending
hdsn-20170630_cal.xml	Edgar Link	unprocessable
hdsn-20170630_def.xml	Edgar Link	unprocessable
hdsn-20170630_lab.xml	Edgar Link	unprocessable
hdsn-20170630_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v472458_10q.htm	Edgar Link	pending
v472458_ex31-1.htm	Edgar Link	pending
v472458_ex31-2.htm	Edgar Link	pending
v472458_ex32-1.htm	Edgar Link	pending
v472458_ex32-2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HDSN
HUDSON TECHNOLOGIES INC /NY Stock $hdsn

2017 Q2 Form 10-Q Financial Statement

#000114420417041734 Filed on August 09, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HDSN HUDSON TECHNOLOGIES INC /NY Stock $hdsn

2017 Q2 Form 10-Q Financial Statement

#000114420417041734 Filed on August 09, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HDSN
HUDSON TECHNOLOGIES INC /NY Stock $hdsn